Yutaka Shimazu
24PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (24)
Sort by Publication Date:
|Mar 19, 2026
Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line Therapy.Yutaka Shimazu
|Jun 28, 2025
Exploratory Analysis of Practical Predictive Indices for the Efficacy of Mogamulizumab in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma.Yutaka Shimazu, Kenta Murotani, Hiroki Kitabayashi
|Feb 28, 2025
Treatment Intensification Based on Residual Disease in Elderly Patients With AML.Yutaka Shimazu, Yayoi Shimazu
|Feb 14, 2025
Glofitamab for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma.Yutaka Shimazu, Yayoi Shimazu
|Feb 11, 2025
Long-Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1-Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy.Hidehiro Itonaga, Yasushi Miyazaki, Takeshi Kondo
Pageof 4
Frequent Collaborators
5 joint publications
Junya Kanda
3 joint publications
Noriko Doki
3 joint publications
Yoshiyuki Onda
3 joint publications
Naoyuki Uchida
2 joint publications
Shin-Ichi Fuchida
2 joint publications
Hirohisa Nakamae
2 joint publications
Satoshi Takahashi
2 joint publications
Yosuke Okada
2 joint publications
Yoshinobu Kanda
2 joint publications
Shuhei Kurosawa
